blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2310529

EP2310529 - MICROVESICLE-BASED COMPOSITIONS AND METHODS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  31.05.2013
Database last updated on 25.09.2024
Most recent event   Tooltip31.05.2013Application deemed to be withdrawnpublished on 03.07.2013  [2013/27]
Applicant(s)For all designated states
Proxy Life Science Holdings, Inc.
30600 San Pasqual Road
Temecula, CA 92591 / US
[2011/16]
Inventor(s)01 / PIETRZKOWSKI, Zbigniew
68 Plateau
Aliso Viejo, CA 92656 / US
 [2012/18]
Former [2011/16]01 / PIETRZKOWSKI, Zbigniew
8594 Henry Street
Dyer, IN 46311 / US
Representative(s)van Kooij, Adriaan, et al
Arnold & Siedsma
Bezuidenhoutseweg 57
2594 AC The Hague / NL
[N/P]
Former [2011/16]van Kooij, Adriaan, et al
Arnold & Siedsma Sweelickplein 1
2517 GK Den Haag / NL
Application number, filing date09767814.819.06.2009
[2011/16]
WO2009US47937
Priority number, dateUS20080074218P20.06.2008         Original published format: US 74218 P
[2011/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009155505
Date:23.12.2009
Language:EN
[2009/52]
Type: A2 Application without search report 
No.:EP2310529
Date:20.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 23.12.2009 takes the place of the publication of the European patent application.
[2011/16]
Search report(s)International search report - published on:EP18.02.2010
ClassificationIPC:C12Q1/68
[2011/16]
CPC:
C12Q1/6886 (EP); C12Q2600/112 (EP); C12Q2600/158 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/16]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN AUF MIKROVESIKELBASIS[2011/16]
English:MICROVESICLE-BASED COMPOSITIONS AND METHODS[2011/16]
French:COMPOSITIONS ET PROCÉDÉS À BASE DE MICROVÉSICULES[2011/16]
Entry into regional phase19.01.2011National basic fee paid 
19.01.2011Designation fee(s) paid 
19.01.2011Examination fee paid 
Examination procedure19.01.2011Examination requested  [2011/16]
06.04.2011Amendment by applicant (claims and/or description)
14.06.2011Despatch of a communication from the examining division (Time limit: M06)
23.03.2012Reply to a communication from the examining division
03.01.2013Application deemed to be withdrawn, date of legal effect  [2013/27]
07.02.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/27]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.06.2011
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
23.03.2012Request for further processing filed
23.03.2012Full payment received (date of receipt of payment)
Request granted
04.04.2012Decision despatched
Fees paidRenewal fee
29.12.2011Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.06.201103   M06   Fee paid on   29.12.2011
30.06.201204   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XDAI]WO2005121369  (SOURCEPHARM INC [US]; PIETRZKOWSKI ZBIGNIEW [US]) [XD] 1-2,9,11,13-14,17-18 * page 3, paragraph 3; claims 33-37 * * page 11, paragraph 3 * * page 19, paragraph 4 - page 21, paragraph 2 * [A] 5,15 [I] 7-8,10,12,16;
 [XI]US2002106684  (KOPRESKI MICHAEL S [US]) [X] 1-2,5,9-15,17-18 * abstract * * paragraph [0005] - paragraph [0009] * * paragraph [0112] - paragraph [0113] * [I] 7-8;
 [XAI]WO0136601  (CHIRON SPA [IT]; ABRIGNANI SERGIO [IT]; PILERI PIERO [IT]) [X] 1-2,9-10 * page 2, line 13 - page 3, line 20 * * page 7, line 12 - page 8, line 20 * [A] 5,15 [I] 7-8,11-12
 [XAI]  - EL-HEFNAWY TALAL; RAJA SIVA; KELLY LORI; BIGBEE WILLIAM L; KIRKWOOD JOHN M; LUKETICH JAMES D; GODFREY TONY E, "Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics.", CLINICAL CHEMISTRY, (20040112), vol. 50, no. 3, ISSN 0009-9147, pages 564 - 573, XP002543914 [X] 1-2,9-14,16-18 * abstract * * page 565, column 1 * [A] 5,15 [I] 7-8

DOI:   http://dx.doi.org/10.1373/clinchem.2003.028506
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.